Cargando…

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis

BACKGROUND: The coronavirus disease 2019 vaccine induces both antibody and T-cell immune responses and has been proven to be effective in preventing coronavirus disease 2019, including its severe disease form, in healthy individuals. However, the details of severe acute respiratory syndrome coronavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atahan, Ersan, Çalışkaner Öztürk, Buket, Akçin, Rüveyda, Sarıbaş, Suat, Kocazeybek, Bekir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874256/ https://www.ncbi.nlm.nih.gov/pubmed/36484365 http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2022-8-64

Ejemplares similares

SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
por: Atahan, Ersan, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2023)

Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
por: Dinç, Harika Öykü, et al.
Publicado: (2022)

Editorial: Blood microbiota in health and disease
por: Demirci, Mehmet, et al.
Publicado: (2023)

Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism
por: Ozturk, Buket Caliskaner, et al.
Publicado: (2021)

Correction to: Investigation of perfusion defects by Q‑SPECT/CT in patients with mild‑to‑moderate course of COVID‑19 and low clinical probability for pulmonary embolism
por: Ozturk, Buket Caliskaner, et al.
Publicado: (2021)

Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children
por: Gulmez, Ruveyda, et al.
Publicado: (2022)

Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection
por: Uysal, Hayriye Kırkoyun, et al.
Publicado: (2016)

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
por: Gareayaghi, Nesrin, et al.
Publicado: (2022)

Investigating the Differences in Polysomnography Results Evaluated According to the Recommended and Alternative Hypopnea Criteria Utilized in the Evaluation of Polysomnography
por: Gencer, Ayşegül, et al.
Publicado: (2022)

mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
por: Tütüncü, Melih, et al.
Publicado: (2023)

Coronavirus Disease 2019 in Patients with Asthma: Case Study from a Tertiary Center Regarding Their Phenotypes and Their Adherence to Asthma Treatment by Telemedicine
por: Çalışkaner Öztürk, Buket, et al.
Publicado: (2022)

Association between presence of Bacillus Calmette–Guerin vaccine scar and coronavirus disease 2019
por: Caliskaner Ozturk, Buket, et al.
Publicado: (2022)

Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Coronavirus-vaccine: Sarcoidosis: case report
Publicado: (2021)

The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism
por: Özbey, Doğukan, et al.
Publicado: (2023)

Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
por: Casenaz, Alice, et al.
Publicado: (2022)

Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2023)

Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus
por: Chang, Chi-Chieh, et al.
Publicado: (2023)

Problems encountered in conventional HIV 1/2 Algorithms: lack of necessity for immunoblot assays to confirm repeated ELISA reactive results
por: Yuksel, Pelin, et al.
Publicado: (2018)

BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism
por: Zubarioglu, Tanyel, et al.
Publicado: (2023)

Detection of A2143G, A2142C, and A2142G Point Mutations with Real-Time PCR in Stool Specimens from Children Infected with Helicobacter pylori
por: Gareayaghi, Nesrin, et al.
Publicado: (2022)

Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice
por: Ababneh, Mustafa, et al.
Publicado: (2019)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Association between human leukocyte antigen gene polymorphisms and multiple EPIYA-C repeats in gastrointestinal disorders
por: Saribas, Suat, et al.
Publicado: (2020)

Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation
por: Pillai, Shiv
Publicado: (2022)

Vaccination of racing greyhounds: effects on humoral and cellular immunity
por: McMillen, G.L., et al.
Publicado: (1995)

Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency
por: Murray, C. E., et al.
Publicado: (2023)

Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study
por: Goggins, Eibhlin, et al.
Publicado: (2022)

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023)

Treatment adherence and anxiety levels of bronchiectasis patients in the COVID-19 pandemic
por: Borekci, Sermin, et al.
Publicado: (2023)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
por: Sun, Clare, et al.
Publicado: (2021)

Humoral and cellular immune memory to four COVID-19 vaccines
por: Zhang, Zeli, et al.
Publicado: (2022)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
por: Morgans, Heather A., et al.
Publicado: (2022)

Investigation of the frequency of obstructive sleep apnoea syndrome in patients with subclinical hypothyroidism
por: Gencer, Aysegul, et al.
Publicado: (2022)

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
por: Bai, Bingke, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c860e4vepm77b3t4a8vqit76da